Americans’ access to lifesaving medication should not rely on supply chains controlled by foreign countries. The Pharmaceutical Investment Oversight and Accountability Act would help shine a light on foreign influence in our drug supply chain and bring overdue transparency to the public health and national security threats posed by overreliance on foreign capital and manufacturing. As the top Democrat on the Senate Aging Committee, I will keep fighting to build better oversight tools to address modern supply chain risks and make sure every American has access to the medicines they need.
Editor's note · Context
Highlighting the importance of the Pharmaceutical Investment Oversight and Accountability Act.
Share
More from Kirsten Gillibrand
These federal investments will support essential upgrades to aging infrastructure, expand childcare access, create jobs, and drive economic growth across Upstate New York.
Republicans have failed the American people with a record that has ripped away health care and raised costs on families, and they know voters will hold them accountable in November — which is exactly why they are rewriting the rules in an…
This $14 million federal investment from the Bipartisan Infrastructure Law is a major boost for cleaning up contaminated sites across New York that pose serious health and infrastructure risks. The Brownfields program is funding more than…





